Search Results 2041-2050 of 23295 for Treatment
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Concussion · Request an Appointment · Symptoms & causes · Diagnosis & treatment ... Diagnosis & treatment. July 18, 2026. Print. Living with concussion? Connect ...
Chimeric antigen receptor T-cell Therapy is a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
... treatment in a caring environment. Depending on your needs, your team may include doctors from several medical specialties to give you the best possible ...
24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension. Participation eligibility. Participant ...
This adult residential treatment facility houses people with serious mental illnesses who are attempting to move back into their communities after more- ...
intravitreal aflibercept (2.0 mg) every 4 weeks. SCORE2 aims to determine if bevacizumab is non-inferior to aflibercept for the treatment of macular edema ...
... treatment (eg, anti-CD20-based treatment). This medicine is also used to ... treatment in patients who have received at least 2 previous treatments.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.